On the heels of the development of a history-making novel coronavirus vaccine, University of Pennsylvania is investing $100 million into a new center of precision engineering for health-related research.
Penn’s Center for Precision Engineering for Health inside the School of Engineering and Applied Science will be formed over the next several years, the university announced this week. The Center is focusing on precision-engineered biomaterials, Penn Engineering Dean Vijay Kumar told Technical.ly in an email, because they are “key” to vaccines, pharmaceuticals and antibiotics, particularly for personalized medicines.
